Skip to main content
Top

Tip

Swipe om te navigeren naar een ander hoofdstuk

2021 | OriginalPaper | Hoofdstuk

12. Tumoren bij kinderen

Auteur : MD, PhD G. O. R. J. Janssens

Gepubliceerd in: Radiotherapie bij de oncologische patiënt

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Inhoud – 1 Inleiding – 2 Hemato-oncologie – 3 Neuro-oncologie – 4 Solide tumoren – Een op de drie kinderen met kanker wordt in de loop van het behandeltraject bestraald. De combinatie van de vele zeldzame ziektebeelden en de grote impact van de behandeling op het zich ontwikkelende kind maken kinderradiotherapie complex. Dit hoofdstuk omvat enkele algemene feiten en reflecties rond radiotherapie bij kinderen, alsook een overzicht van de vaker voorkomende hematologische, solide en neuro-oncologische tumoren waarvoor radiotherapie-indicaties bestaan.
Literatuur
1.
go back to reference Pieters R, De Groot-Kruseman H, Van der Velden V, et al. Successful therapy reduction and intensification for childhood acute lymphoblastic leukemia based on minimal residual disease monitoring: study ALL10 from the Dutch childhood oncology group. J Clin Oncol. 2016;34(22):2591–601. CrossRef Pieters R, De Groot-Kruseman H, Van der Velden V, et al. Successful therapy reduction and intensification for childhood acute lymphoblastic leukemia based on minimal residual disease monitoring: study ALL10 from the Dutch childhood oncology group. J Clin Oncol. 2016;34(22):2591–601. CrossRef
2.
go back to reference Reedijk AM, Klein K, Coebergh JW, et al. Improved survival for children and young adolescents with acute myeloid leukemia: a Dutch study on incidence, survival and mortality. Leukemia. 2019;33(6):1349–59. CrossRef Reedijk AM, Klein K, Coebergh JW, et al. Improved survival for children and young adolescents with acute myeloid leukemia: a Dutch study on incidence, survival and mortality. Leukemia. 2019;33(6):1349–59. CrossRef
3.
go back to reference Mauz-Korholz C, Metzger ML, Kelly KM, et al. Pediatric hodgkin lymphoma. J Clin Oncol. 2015;33(27):2975–85. CrossRef Mauz-Korholz C, Metzger ML, Kelly KM, et al. Pediatric hodgkin lymphoma. J Clin Oncol. 2015;33(27):2975–85. CrossRef
4.
go back to reference Cherlow JM, Shaw DW, Margraf LR, et al. Conformal radiation therapy for pediatric patients with low-grade glioma: results from the children’s oncology group phase 2 study ACNS0221. Int J Radiat Oncol Biol Phys. 2019;103(4):861–8. CrossRef Cherlow JM, Shaw DW, Margraf LR, et al. Conformal radiation therapy for pediatric patients with low-grade glioma: results from the children’s oncology group phase 2 study ACNS0221. Int J Radiat Oncol Biol Phys. 2019;103(4):861–8. CrossRef
5.
go back to reference Janssens GO, Jansen MH, Lauwers SJ, et al. Hypofractionation vs conventional radiation therapy for newly diagnosed diffuse intrinsic pontine glioma: a matched-cohort analysis. Int J Radiat Oncol Biol Phys. 2013;85(2):315–20. CrossRef Janssens GO, Jansen MH, Lauwers SJ, et al. Hypofractionation vs conventional radiation therapy for newly diagnosed diffuse intrinsic pontine glioma: a matched-cohort analysis. Int J Radiat Oncol Biol Phys. 2013;85(2):315–20. CrossRef
6.
go back to reference Taylor MD, Northcott PA, Korshunov A, et al. Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol. 2012;123(4):465–72. CrossRef Taylor MD, Northcott PA, Korshunov A, et al. Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol. 2012;123(4):465–72. CrossRef
7.
go back to reference Merchant TE, Bendel AE, Sabin ND, et al. Conformal radiation therapy for pediatric ependymoma, chemotherapy for incompletely resected ependymoma, and observation for completely resected, supratentorial ependymoma. J Clin Oncol. 2019;37(12):974–83. CrossRef Merchant TE, Bendel AE, Sabin ND, et al. Conformal radiation therapy for pediatric ependymoma, chemotherapy for incompletely resected ependymoma, and observation for completely resected, supratentorial ependymoma. J Clin Oncol. 2019;37(12):974–83. CrossRef
8.
go back to reference Van den Heuvel-Eibrink MM, Hol JA, Pritchard-Jones K, et al. Position paper: rationale for the treatment of wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol. Nat Rev Urol. 2017;14(12):743–52. CrossRef Van den Heuvel-Eibrink MM, Hol JA, Pritchard-Jones K, et al. Position paper: rationale for the treatment of wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol. Nat Rev Urol. 2017;14(12):743–52. CrossRef
9.
go back to reference Ladenstein R, Potschger U, Valteau-Couanet D, et al. Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial. Lancet Oncol. 2018;19(12):1617–29. CrossRef Ladenstein R, Potschger U, Valteau-Couanet D, et al. Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial. Lancet Oncol. 2018;19(12):1617–29. CrossRef
10.
go back to reference Foulon S, Brennan B, Gaspar N, et al. Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E.W.I.N.G. group. Eur J Cancer. 2016;61:128–36. CrossRef Foulon S, Brennan B, Gaspar N, et al. Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E.W.I.N.G. group. Eur J Cancer. 2016;61:128–36. CrossRef
go back to reference Eduard CH, Louis SC, editors. Pediatric radiation oncology. 6th ed. Philadelphia: Lippincott and Wilkins; 2016. Eduard CH, Louis SC, editors. Pediatric radiation oncology. 6th ed. Philadelphia: Lippincott and Wilkins; 2016.
go back to reference Thomas EM, Kortmann R-D, editors. Pediatric radiation oncology. 1st ed. Cham: Springer; 2018. Thomas EM, Kortmann R-D, editors. Pediatric radiation oncology. 1st ed. Cham: Springer; 2018.
Metagegevens
Titel
Tumoren bij kinderen
Auteur
MD, PhD G. O. R. J. Janssens
Copyright
2021
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/16013_2020_19